Latest Regulatory Oversight News

Snow Lake Resources has secured a crucial no objection from Australia’s Foreign Investment Review Board for its proposed acquisition of Global Uranium and Enrichment Limited, paving the way for the transaction’s next steps. The independent GUE board unanimously recommends shareholders back the scheme, pending expert endorsement.

Activeport Group Ltd has revised the timetable for its pro-rata bonus issue of unquoted options, outlining key dates and eligible shareholders across multiple countries.

MyState Limited has reached a pivotal merger milestone by consolidating Auswide Bank under its single banking licence, aiming to unlock significant cost synergies while maintaining customer continuity.

Seven West Media has secured crucial approval from the Australian Communications and Media Authority, advancing Southern Cross Media's acquisition plans. The upcoming scheme meeting in December will be pivotal for shareholders.

Dalrymple Bay Infrastructure Limited has reaffirmed its position as the world’s largest metallurgical coal export facility with full contracted capacity through 2028 and unveiled detailed plans for a significant terminal expansion.

Vintage Energy has signed a conditional agreement to acquire Metgasco’s 25% stakes in key Southern Flank gas joint ventures and is considering acquiring Bridgeport’s stakes, aiming to accelerate development of the Vali and Odin gas fields.

The Takeovers Panel has issued interim orders extending the deadline for Mayne Pharma's takeover scheme with Cosette Pharmaceuticals, preventing termination without consent and maintaining the status quo.

Sequoia Financial Group’s subsidiary InterPrac Financial Planning faces ASIC civil penalty proceedings over past investment advice but plans a robust defence.

Mt Malcolm Mines NL has suspended trading of its M2MOA securities pending regulatory compliance, signaling a cautious pause for investors.

NeuroScientific Biopharmaceuticals has initiated treatment of its fourth patient under the Special Access Scheme for StemSmart™, progressing towards a Phase 2 trial targeting severe Crohn’s disease.

James Hardie Industries faces intense scrutiny from the ASX after its share price dropped sharply and trading volumes spiked, prompting urgent questions about undisclosed information.

SportsHero Limited has voluntarily suspended trading on the ASX pending a Supreme Court decision regarding its failure to lodge required cleansing notices for recent share issues.